These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7042845)

  • 1. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
    Kobayashi Y; Asada M; Higuchi M; Osawa T
    J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cell hybridomas producing cytotoxic lymphokines: induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester.
    Ware CF; Green LM; Reade J; Stern ML; Berger AE
    Lymphokine Res; 1986; 5(4):313-24. PubMed ID: 2878123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
    van Dongen JJ; Geurts van Kessel AH; Wolvers-Tettero IL; Versnel MA; van Oudenaren A; Schoenmaker E; Hagemeijer A
    J Immunol; 1986 Aug; 137(3):1047-53. PubMed ID: 3487584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a human X mouse T cell hybridoma and identification of a clone secreting and binding interleukin-2.
    Durrant LG; Parkar M; Kenworthy N; Taylor GM
    Immunology; 1984 May; 52(1):117-28. PubMed ID: 6609121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cell lines secreting lymphokines. I. Establishment of T-T hybridomas.
    Epstein N; Gozes Y; Halmann M; Kobiler D
    Dev Biol Stand; 1987; 66():439-46. PubMed ID: 3108054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell hybridomas producing lymphokines. II. Enhancement of lymphotoxin secretion from human T-cell hybridomas by phorbol myristate acetate.
    Asada M; Higuchi M; Kobayashi Y; Osawa T
    Cell Immunol; 1983 Apr; 77(1):150-60. PubMed ID: 6340837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human suppressor T cell hybridomas.
    Greene WC; Fleisher TA; Nelson DL; Waldmann TA
    J Immunol; 1982 Nov; 129(5):1986-92. PubMed ID: 6214585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors.
    Higuchi M; Asada M; Kobayashi Y; Osawa T
    Cell Immunol; 1983 Jun; 78(2):257-65. PubMed ID: 6305517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-T cell hybridomas: development and applications.
    Fox FE; Platsoucas CD
    Hum Antibodies Hybridomas; 1990; 1(1):3-9. PubMed ID: 2103350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer.
    Friedman SM; Thompson G; Halper JP; Knowles DM
    J Immunol; 1982 Feb; 128(2):935-40. PubMed ID: 6976389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-producing human T-cell hybridomas.
    Kobayashi Y; Osawa T
    Lymphokine Res; 1983; 2(3):91-5. PubMed ID: 6379317
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage-chemotactic factor-producing T cell hybridomas reactive to phosphorylcholine in I-E-restricted manner.
    Harita S; Sugimura K; Watanabe T
    Eur J Immunol; 1984 Aug; 14(8):692-7. PubMed ID: 6205880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine production by human T cell hybridomas.
    Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
    J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a human T cell hybridoma cell line producing suppressor factor specific for anti-thyroglobulin antibody production.
    Noma T; Yata J
    J Immunol; 1987 May; 138(9):2929-34. PubMed ID: 3494775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factor.
    Foon KA; Rossio JL; Schroff RW; Wahl SM; Ruscetti FW; Abrams PG; Rager HC; Pickeral SF; Fidler IJ
    Hybridoma; 1985; 4(3):211-22. PubMed ID: 3930388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a human antigen specific helper factor secreted by a T cell hybrid.
    Richardson BC
    J Clin Lab Immunol; 1988 Jan; 25(1):35-9. PubMed ID: 2455056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
    Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
    J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.